PubMed

Analytische Validierung des Multitarget Stuhl RNA Tests für Kolorektalkrebs-Screening.

PMID: 39001727 · 2024-07-10

E, r, i, c, a, , K, , B, a, r, n, e, l, l, ;, , J, a, c, k, , L, a, n, d, ;, , K, i, m, b, e, r, l, y, , K, r, u, s, e, ;, , M, a, y, a, , C, , S, c, o, t, t, ;, , B, e, n, , W, e, d, e, k, i, n, g, ;, , C, a, t, h, e, r, i, n, e, , M, o, r, r, i, s, o, n, ;, , C, l, a, y, t, o, n, , G, r, a, s, s, ;, , A, n, n, , Z, u, n, i, g, a, ;, , E, l, i, z, a, b, e, t, h, , M, , W, u, r, t, z, l, e, r, ;, , E, r, i, c, , J, , D, u, n, c, a, v, a, g, e

ZeitschriftThe Journal of molecular diagnostics : JMD

Jahr2024-07-10

PMID39001727

Zusammenfassung

The multitarget stool RNA (mt-sRNA) test (ColoSense) is a noninvasive diagnostic test that screens for colorectal cancer and advanced adenomas in average-risk individuals aged 45 years and older. The mt-sRNA test incorporates a commercially available fecal immunochemical test, concentration of eight RNA transcripts, and participant-reported smoking status. As part of the CRC-PREVENT (Colorectal Cancer and Pre-Cancerous Adenoma Non-Invasive Detection Test) clinical trial, 12 analytical validation

Offizielle Quelle

Auf PubMed ansehen →

Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.